The daily dose: October 27, 2021

# Covaxin saga continues: The Technical Advisory Group reviewing Covaxin will reconvene on November 3rd for the final risk-benefit assessment. And thi

Comments

Popular posts from this blog

BJP’s victory in local body polls indicator of coming Assembly polls: Bommai

‘No difference between Congress, PFI’: Karnataka BJP

Karnataka: BJP MLA used HIV positive women to honey trap rivals, probe launched